Notification Letter and Change Request Form for Registered Shareholders
Filed with HKEX · Stock code 2137 · · 2 pages · English and Chinese
Summary by 6ix AI
This filing is a notification letter from Brii Biosciences Limited regarding the publication of its interim report for a specific year on the company's website. It informs registered shareholders about their options for receiving future corporate communications, either electronically or in printed form. The letter includes a change request form for shareholders to indicate their preferred method of communication.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Brii Biosciences Limited on 6ix
Earlier from Brii Biosciences
- 2026 Interim Report
- Brii Biosciences Provides Corporate Updates and Reports 2026 Interim Financial Results
- Brii Bio Announces Topline End-of-Treatment Data from Phase 2b ENRICH and ENHANCE Studies for the Treatment of Chronic Hepatitis B
- Brii Bio Presents Late-Breaking Data from Its Phase 2 ENSURE Study at EASL Congress 2026, Further Supporting the Potential Role of BRII-179 in Achieving Durable Immunological Control of HBV
- Brii Bio Presents Cross-Study Analysis of Post-Treatment HBsAg Rebound at APASL 2026
Later from Brii Biosciences
- Notification Letter and Request Form for Non-registered Shareholders
- Monthly return of equity issuer on movements in securities for the month ended 30 September 2026
- Grant of share options and restricted share units
- Next Day Disclosure Return
- VOLUNTARY ANNOUNCEMENT Launch of BRiSC, an siRNA Therapeutics Discovery Platform
Follow Brii Biosciences into a list and get an email when it puts out news.
Follow Brii Biosciences